Pharmacokinetics of ABT-335 and Rosuvastatin in Subjects With Normal Renal Function and Renal Impairment.
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2012
At a glance
- Drugs Choline fenofibrate; Rosuvastatin
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 21 Mar 2012 Additional lead trial investigator (Maureen Kelly) identified as reported by ClinicalTrials.gov.
- 21 Mar 2012 Official title amended as reported by ClinicalTrials.gov.
- 26 Nov 2008 New trial record.